CAT members
The European Medicines Agency (EMA) publishes details of the members and alternates of its Committee for Advanced Therapies (CAT).
Human
Advanced therapies
Innovation
The CAT consists of:
All members and alternates serve on the committee for a renewable three year period.
In accordance with the committee rules of procedures, observers from non-EEA authorities with whom there is a confidentiality arrangement may attend the plenary meetings on regular basis. Attendance is reflected in the committee minutes as from 2024.
The list includes each member's and alternate's:
For more information on EMA's policy on handling competing interests for committee members, see Handling competing interests.
For contact details, please refer to the affiliated organisations of individual committee members.
Members appointed from within the CHMP
Members appointed by the Member States
Members representing patients' organisations appointed by the European Commission
Members representing clinicians appointed by the European Commission